🇺🇸 FDA
Patent

US 10028999

PAR-1 based therapeutic conjugates and uses thereof

granted A61KA61K31/519A61K38/00

Quick answer

US patent 10028999 (PAR-1 based therapeutic conjugates and uses thereof) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/519, A61K38/00, A61K38/1796, A61K38/57